Gene-based immunotherapy in osteosarcoma: from oncolytic vectors to engineered immune cells
Osteosarcoma remains difficult to cure once it metastasizes, recurs, or becomes resistant to chemotherapy. Surgery combined with multi-drug chemotherapy improves outcomes in localized disease, but outcomes for high-risk patients have plateaued, prompti…